{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T00:20:26Z","timestamp":1794442826103,"version":"4.9.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T00:00:00Z","timestamp":1507593600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s10067-017-3864-6","type":"journal-article","created":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T07:08:30Z","timestamp":1507619310000},"page":"1667-1673","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Clinical significance of fecal calprotectin for the early diagnosis of abdominal type of Henoch\u2013Schonlein purpura in children"],"prefix":"10.1007","volume":"37","author":[{"given":"Xu","family":"Teng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiyun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,10]]},"reference":[{"key":"3864_CR1","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0140-6736(02)11279-7","volume":"360","author":"JM Gardner-Medwin","year":"2002","unstructured":"Gardner-Medwin JM, Dolezalova P, Cummins C et al (2002) Incidence of Henoch-Schonlein purpura, Kawasaki disease and rare vasculitides in children of different ethnic origins. Lancet 360:1197\u20131202","journal-title":"Lancet"},{"issue":"1","key":"3864_CR2","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s13730-014-0148-8","volume":"4","author":"T Yamazaki","year":"2015","unstructured":"Yamazaki T, Akimoto T, Iwazu Y et al (2015) Henoch-Sch\u00f6nlein purpura complicated with severe gastrointestinal bleeding. CEN Case Rep 4(1):106\u2013111","journal-title":"CEN Case Rep"},{"issue":"3","key":"3864_CR3","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4329\/wjr.v7.i3.66","volume":"7","author":"P Prathiba Rajalakshmi","year":"2015","unstructured":"Prathiba Rajalakshmi P, Srinivasan K (2015) Gastrointestinal manifestations of Henoch-Schonlein purpura: a report of two cases. World J Radiol 7(3):66\u201369","journal-title":"World J Radiol"},{"issue":"5","key":"3864_CR4","first-page":"CD010714","volume":"19","author":"SH Luo","year":"2016","unstructured":"Luo SH, Guo Q, Liu GJ (2016) Fasting for haemostasis in children with gastrointestinal bleeding. Cochrane Database Syst Rev 19(5):CD010714","journal-title":"Cochrane Database Syst Rev"},{"key":"3864_CR5","doi-asserted-by":"crossref","first-page":"c3369","DOI":"10.1136\/bmj.c3369","volume":"341","author":"PF Rheenen van","year":"2010","unstructured":"van Rheenen PF, de Vijver EV, Fidler V (2010) Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. BMJ 341:c3369","journal-title":"BMJ"},{"issue":"8","key":"3864_CR6","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1080\/00365521.2017.1315740","volume":"52","author":"L Kwapisz","year":"2017","unstructured":"Kwapisz L, Gregor J, Chande N et al (2017) The utility of fecal calprotectin in predicting the need for escalation of therapy in inflammatory bowel disease. Scand J Gastroenterol 52(8):846\u2013850","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"3864_CR7","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1590\/S0004-28032015000100011","volume":"52","author":"LM Kotze","year":"2015","unstructured":"Kotze LM, Nisihara RM, Marion SB et al (2015) FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms. Arq Gastroenterol 52(1):50\u201354","journal-title":"Arq Gastroenterol"},{"issue":"6","key":"3864_CR8","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s00277-017-2974-1","volume":"96","author":"E Metafuni","year":"2017","unstructured":"Metafuni E, Giammarco S, De Ritis DG et al (2017) Fecal but not serum calprotectin is a potential marker of GVHD after stem cell transplantation. Ann Hematol 96(6):929\u2013933","journal-title":"Ann Hematol"},{"issue":"4","key":"3864_CR9","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/00005176-200310000-00013","volume":"37","author":"UL Fagerberg","year":"2003","unstructured":"Fagerberg UL, Loof L, Merzoug RD et al (2003) Fecal calprotectin levels in healthy children studied with an improved assay. J Pediatr Gastroenterol Nutr 37(4):468\u2013472","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"3864_CR10","first-page":"502","volume":"51","author":"The Subspecialty Group of immunology, Society of Pediatrics, Chinese Medical Association ,The Editorial Board of Chinese Journal of Pediatrics","year":"2013","unstructured":"The Subspecialty Group of immunology, Society of Pediatrics, Chinese Medical Association ,The Editorial Board of Chinese Journal of Pediatrics (2013) Evidence-Based Recommendations for the Diagnosis and Treatment of Pediatric Henoch-Schonlein purpura. chin. J Pediatr 51(5):502\u2013507","journal-title":"J Pediatr"},{"issue":"1","key":"3864_CR11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.rdc.2014.09.006","volume":"41","author":"RG Micheletti","year":"2015","unstructured":"Micheletti RG, Werth VP (2015) Small vessel vasculitis of the skin. Rheum Dis Clin N Am 41(1):21\u201332","journal-title":"Rheum Dis Clin N Am"},{"issue":"11","key":"3864_CR12","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.vaccine.2016.09.024","volume":"35","author":"A Woerner","year":"2017","unstructured":"Woerner A, Rudin C, Bonetto C et al (2017) Brighton Collaboration lgA Vasculitis (Henoch\u2013Sch\u00f6nlein) Working Group. IgA vasculitis (Henoch-Sch\u00f6nlein): case definition andguidelines for data collection, analysis, and presentation of immunisation safety data. Vaccine 35(11):1559\u20131566","journal-title":"Vaccine"},{"issue":"1","key":"3864_CR13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1755-7682-4-31","volume":"4","author":"A Hamzaoui","year":"2011","unstructured":"Hamzaoui A, Melki W, Harzallah O et al (2011) Gastrointestinal involvement revealing Henoch-Schonlein purpura in adults: report of three cases and review of the literature. Int Arch Med 4(1):31","journal-title":"Int Arch Med"},{"issue":"166","key":"3864_CR14","first-page":"62","volume":"46","author":"N Grover","year":"2007","unstructured":"Grover N, Sankhyan N, Bisht JP et al (2007) A five year review of clinical profile in HSP. JNMA J Nepal Med Assoc 46(166):62\u201365","journal-title":"JNMA J Nepal Med Assoc"},{"issue":"3","key":"3864_CR15","doi-asserted-by":"crossref","first-page":"e880","DOI":"10.1542\/peds.2013-2213","volume":"134","author":"A Fatima","year":"2014","unstructured":"Fatima A, Gibson DP (2014) Pneumatosis intestinalis associated with Henoch-Sch\u00f6nlein purpura. Pediatrics 134(3):e880\u2013e883","journal-title":"Pediatrics"},{"issue":"9","key":"3864_CR16","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1080\/00365520802101861","volume":"43","author":"Y Zhang","year":"2008","unstructured":"Zhang Y, Huang X (2008) Gastrointestinal involvement in Henoch-Sch\u00f6nlein purpura. Scand J Gastroenterol 43(9):1038\u20131043","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"3864_CR17","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/path.2394","volume":"216","author":"D Foell","year":"2008","unstructured":"Foell D, Wittkowski H, Ren Z et al (2008) Phagocyte-specific S100 proteins are released from affected mucosa and promote immunoresponses during inflammatory bowel disease. J Pathol 216(2):183\u2013192","journal-title":"J Pathol"},{"key":"3864_CR18","doi-asserted-by":"crossref","unstructured":"Campeotto F, Suau A, Kapel N et al (2011) A fermented formula in pre-term infants: clinical tolerance, gut microbiota, downregulation of faecal calprotectin and upregulation of faecal secretory IgA. Br J Nutr, 28;105(12):1843\u20131851","DOI":"10.1017\/S0007114510005702"},{"issue":"11","key":"3864_CR19","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1080\/00365520701416709","volume":"42","author":"ST Leach","year":"2007","unstructured":"Leach ST, Yang Z, Messina I et al (2007) Serum and mucosal S100 proteins, calprotectin (S100A8\/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease. Scand J Gastroenterol 42(11):1321\u20131331","journal-title":"Scand J Gastroenterol"},{"issue":"5","key":"3864_CR20","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1097\/MIB.0000000000000349","volume":"21","author":"M Calafat","year":"2015","unstructured":"Calafat M, Cabr\u00e9 E, Ma\u00f1osa M et al (2015) High within-day variability of fecal calprotectin levels in patients with active ulcerative colitis: what ss the best timing for stool sampling? Inflamm Bowel Dis 21(5):1072\u20131076","journal-title":"Inflamm Bowel Dis"},{"issue":"12","key":"3864_CR21","first-page":"1993","volume":"60","author":"O Hradsky","year":"2014","unstructured":"Hradsky O, Ohem J, Mitrova K et al (2014) Fecal calprotectin levels in children is more tightly associated with histological than with macroscopic endoscopy findings. Clin Lab 60(12):1993\u20132000","journal-title":"Clin Lab"},{"issue":"8","key":"3864_CR22","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3345\/kjp.2014.57.8.351","volume":"57","author":"JM Yoon","year":"2014","unstructured":"Yoon JM, Yi Park J, Ko KO et al (2014) Fecal calprotectin concentration in neonatal necrotizing enterocolitis. Korean J Pediatr 57(8):351\u2013356","journal-title":"Korean J Pediatr"},{"issue":"5","key":"3864_CR23","first-page":"312","volume":"127","author":"A Moniuszko","year":"2017","unstructured":"Moniuszko A, G\u0142uszek S, Rydzewska G (2017) Rapid fecal calprotectin test for prediction of mucosal inflammation in ulcerative colitis and Crohn disease: a prospective cohort study. Pol Arch Intern Med 127(5):312\u2013318","journal-title":"Pol Arch Intern Med"},{"issue":"6","key":"3864_CR24","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.autrev.2015.01.018","volume":"14","author":"I Marie","year":"2015","unstructured":"Marie I, Leroi AM, Menard JF et al (2015) Fecal calprotectin in systemic sclerosis and review of the literature. Autoimmun Rev 14(6):547\u2013554","journal-title":"Autoimmun Rev"},{"issue":"3","key":"3864_CR25","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/MIB.0000000000000652","volume":"22","author":"E Zittan","year":"2016","unstructured":"Zittan E, Kelly OB, Kirsch R et al (2016) Low fecal calprotectin correlates with histological remission and mucosal healing in ulcerative colitis and colonic Crohn\u2019s Disease. Inflamm Bowel Dis 22(3):623\u2013630","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"3864_CR26","first-page":"53","volume":"13","author":"I Bjarnason","year":"2017","unstructured":"Bjarnason I (2017) The use of fecal calprotectin in inflammatory bowel disease. Gastroenterol Hepatol (N Y) 13(1):53\u201356","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"6","key":"3864_CR27","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1097\/MIB.0000000000001082","volume":"23","author":"A Heida","year":"2017","unstructured":"Heida A, Park KT, van Rheenen PF (2017) Clinical utility of fecal calprotectin monitoring in asymptomatic patients with inflammatory bowel disease: a systematic review and practical guide. Inflamm Bowel Dis 23(6):894\u2013902","journal-title":"Inflamm Bowel Dis"},{"issue":"7\u20138","key":"3864_CR28","first-page":"841","volume":"58","author":"G Aydemir","year":"2012","unstructured":"Aydemir G, Cekmez F, Tanju IA et al (2012) Increased fecal calprotectin in preterm infants with necrotizing enterocolitis. Clin Lab 58(7\u20138):841\u2013844","journal-title":"Clin Lab"},{"issue":"3","key":"3864_CR29","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/MEG.0000000000000284","volume":"27","author":"K Al","year":"2015","unstructured":"Al K, Baran M, Ince FD et al (2015) Faecal calprotectin levels in children with Henoch-Sch\u00f6nlein purpura: is this a new marker for gastrointestinal involvement? Eur J Gastroenterol Hepatol 27(3):254\u2013258","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"3864_CR30","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1586\/17474124.2014.869476","volume":"8","author":"E Burri","year":"2014","unstructured":"Burri E, Beglinger C (2014) The use of fecal calprotectin as a biomarker in gastrointestinal disease. Expert Rev Gastroenterol Hepatol 8(2):197\u2013210","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"5","key":"3864_CR31","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1651-2227.2010.01698.x","volume":"99","author":"G Flagstad","year":"2010","unstructured":"Flagstad G, Helgeland H, Markestad T (2010) Faecal calprotectin concentrations in children with functional gastrointestinal disorders diagnosed according to the Pediatric Rome III criteria. Acta Paediatr 99(5):734\u2013737","journal-title":"Acta Paediatr"},{"issue":"5","key":"3864_CR32","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jpeds.2008.04.062","volume":"153","author":"RJ Shulman","year":"2008","unstructured":"Shulman RJ, Eakin MN, Czyzewski DI et al (2008) Increased gastrointestinal permeability and gut inflammation in children with functional abdominal pain and irritable bowel syndrome. J Pediatr 153(5):646\u2013650","journal-title":"J Pediatr"},{"issue":"7","key":"3864_CR33","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.dld.2004.02.009","volume":"36","author":"R Berni Canani","year":"2004","unstructured":"Berni Canani R, Rapacciuolo L, Romano MT et al (2004) Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice. Dig Liver Dis 36(7):467\u2013470","journal-title":"Dig Liver Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-017-3864-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3864-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3864-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T04:26:06Z","timestamp":1659587166000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-017-3864-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,10]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["3864"],"URL":"https:\/\/doi.org\/10.1007\/s10067-017-3864-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,10]]}}}